SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
SEC Accession No. 0000893838-05-000133
Filing Date
2005-05-23
Accepted
2005-05-23 10:32:05
Documents
1

Document Format Files

Seq Description Document Type Size
1 rex13dchung.txt SC 13D/A 11621
  Complete submission text file 0000893838-05-000133.txt   13477
Mailing Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850
Business Address 9620 MEDICAL CENTER DRIVE ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Subject) CIK: 0001228627 (see all company filings)

IRS No.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-79996 | Film No.: 05849901
SIC: 2834 Pharmaceutical Preparations

Mailing Address 756 JIGOK-DONG POSTECH FACULTY APT 9-201 POHANG M5 790-751
Business Address 82 (54) 279-2103
Chung Sung-Kee (Filed by) CIK: 0001314356 (see all company filings)

Type: SC 13D/A